MDXG

MDXG EBITDA Growth

-57.46%TTM

Period ending:

MDXG TTM EBITDA YoY %%
MDXG TTM EBITDA YoY %5607148.77%-52297257.47%
2008-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

MDXG ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 71 observations from Dec 31, 2008 to Jun 30, 2026.

Mimedx Group Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-57.4583%
-9.6745%
27.8962%
7.0054%
-16.4125%
17.5465%
60.7306%
156.3662%
713.1803%
546.0356%
293.5831%
242.1038%
166.445%
-361.8176%
-10,723.8034%
-3.6299%
52.0715%
91.5519%
100.5251%
-984.1849%
-215.2313%
-373.5946%
-387.0171%
-17.5966%
244.4495%
287.7823%
-25.7034%
-104.6817%
-137.1265%
-93.8263%
-65.2436%
-26.0409%
21.8389%
54.2397%
82.1643%
52.8372%
30.3567%
13.2534%
2.5502%
11.1056%
27.0508%
87.4376%
193.7403%
583.1843%
3,496.5573%
1,447.3549%
1,803.7525%
1,051.2655%
-22.0495%
-705.3728%
-275.3846%
79.4382%
83.708%
103.3068%
98.1923%
78.9148%
68.7995%
47.6799%
17.8134%
-16.2069%
-37.9551%
-57.4896%
-42.1823%
18.0986%
27.4712%
40.2568%
99.9603%
99.9484%
99.943%
99.9366%
-46,693,605.2484%

Compare ebitda growth

All MDXG financial metrics · MDXG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.